PHYTOZINE RINGWORM TREATMENT MAXIMUM STRENGTH

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: PHYTOZINE RINGWORM TREATMENT MAXIMUM STRENGTH
Generic name: TOLNAFTATE
Manufacturer: The Sisquoc Healthcare Corporation
Product type: HUMAN OTC DRUG
SPL set ID: 5dff6ee7-f7a9-4841-8357-6b0801d253f1
SPL ID: 334f4f69-fe0c-c703-e063-6394a90adecf
Version: 6
Effective date: 2025-04-21
Source export date: 2026-09-28
Source partition: 3
Source file: https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/fd09911bd1bc81f7f2faeb048e63855fe224e494376ae919a0035190e315c050/drug-label-0003-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:20:40

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M005	openfda.application_number
brand name		PHYTOZINE RINGWORM TREATMENT MAXIMUM STRENGTH	openfda.brand_name
generic name		TOLNAFTATE	openfda.generic_name
manufacturer name		The Sisquoc Healthcare Corporation	openfda.manufacturer_name
ndc	package	71229-101-11	openfda.package_ndc
ndc	product	71229-101	openfda.product_ndc
ndc11	package	71229010111	derived:openfda.package_ndc
rxcui		199126	openfda.rxcui
spl id		334f4f69-fe0c-c703-e063-6394a90adecf	id
spl set id		5dff6ee7-f7a9-4841-8357-6b0801d253f1	set_id
unii		06KB629TKV	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS FOR EXTERNAL USE ONLY. WHEN USING THIS PRODUCT AVOID CONTACT WITH THE EYES. STOP USE AND ASK A DOCTOR IF IRRITATION OCCURS THERE IS NO IMPROVEMENT WITHIN 4 WEEKS. DO NOT USE ON CHILDREN UNDER 2 YEARS OF AGE UNLESS DIRECTED BY A DOCTOR.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.